NovaBay Pharmaceuticals Inc. (NBY)

2.87
0.18 5.90
AMEX : Health Technology
Prev Close 3.05
Open 3.02
Day Low/High 2.80 / 3.03
52 Wk Low/High 2.25 / 5.00
Volume 11.90K
Avg Volume 5.80K
Exchange AMEX
Shares Outstanding 17.09M
Market Cap 52.12M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

IIROC Trading Resumption - NBY

IIROC Trading Resumption - NBY

IIROC Trading Halt - NBY

IIROC Trading Halt - NBY

NovaBay Pharmaceuticals Reports 2017 Fourth Quarter And Full Year Financial Results

NovaBay Pharmaceuticals Reports 2017 Fourth Quarter And Full Year Financial Results

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three...

NovaBay Pharmaceuticals To Hold 2017 Fourth Quarter And Full Year Conference Call On March 20, 2018

NovaBay Pharmaceuticals To Hold 2017 Fourth Quarter And Full Year Conference Call On March 20, 2018

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova ® lid and lash hygiene product for the domestic eye care market, announces...

NovaBay Pharmaceuticals Completes $6.0 Million Private Placement

NovaBay Pharmaceuticals Completes $6.0 Million Private Placement

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focused on commercializing Avenova ®, a prescription product for the domestic eye care market, announces the completion of a...

NovaBay Pharmaceuticals Announces Preliminary Sales For 2017 Fourth Quarter And Full Year

NovaBay Pharmaceuticals Announces Preliminary Sales For 2017 Fourth Quarter And Full Year

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® lid and lash hygiene for the domestic eye care market, announces that...

NovaBay Pharmaceuticals Receives Stockholder Approval For Proposed $10.32 Million Financing Agreement

NovaBay Pharmaceuticals Receives Stockholder Approval For Proposed $10.32 Million Financing Agreement

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, announces stockholder approval to issue...

NovaBay Pharmaceuticals Regains Compliance With NYSE American Continued Listing Standards

NovaBay Pharmaceuticals Regains Compliance With NYSE American Continued Listing Standards

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova lid and lash hygiene for the domestic eye care market, announces that it has...

NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer

NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for lid and lash hygiene in the domestic eye care market, announces the...

NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results

NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for lid and lash hygiene in the domestic eye care market, reports financial...

NovaBay Pharmaceuticals To Hold Third Quarter 2017 Conference Call On November 14

NovaBay Pharmaceuticals To Hold Third Quarter 2017 Conference Call On November 14

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova ® lid and lash hygiene product for the domestic eye care market, announces...

NovaBay Pharmaceuticals Receives Notification Of Noncompliance With Additional NYSE American Continued Listing Standards

NovaBay Pharmaceuticals Receives Notification Of Noncompliance With Additional NYSE American Continued Listing Standards

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces receipt of a letter from NYSE American LLC ("NYSE American" or the "Exchange") on September 14, 2017 stating that it is not in compliance with the...

NovaBay Pharmaceuticals To Present At Rodman & Renshaw 19th Annual Global Investment Conference

NovaBay Pharmaceuticals To Present At Rodman & Renshaw 19th Annual Global Investment Conference

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® lid and lash hygiene for the domestic eye care market, announces that Chief...

NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results

NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for lid and lash hygiene in the domestic eye care market, reports financial results...

NovaBay Pharmaceuticals To Hold 2017 Second Quarter Conference Call On August 10, 2017

NovaBay Pharmaceuticals To Hold 2017 Second Quarter Conference Call On August 10, 2017

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for lid and lash hygiene in the domestic eye care market, announces that it will...

NovaBay Pharmaceuticals Announces CFO Transition

NovaBay Pharmaceuticals Announces CFO Transition

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a specialty pharmaceutical company focusing on commercializing prescription Avenova ® for lid and lash hygiene in the domestic eye care market, announces that...

NovaBay Pharmaceuticals Joins The Russell Microcap Index

NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® lid and lash hygiene for the domestic eye care market, announces that it has...

NovaBay Pharmaceuticals To Present At The 7th Annual LD Micro Invitational

NovaBay ® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® lid and lash hygiene for the domestic eye care market, announces that management is...

NovaBay Pharmaceuticals Receives Noncompliance Notice From NYSE MKT

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) today announced receipt of a letter from NYSE MKT LLC ("NYSE MKT" or the "Exchange") on May 16, 2017, stating that it is not in compliance with the continued listing...

NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a pharmaceutical company focused on commercializing its prescription Avenova ® lid and lash hygiene product for the domestic eye care market, reports financial...

NovaBay Pharmaceuticals To Hold 2017 First Quarter Conference Call On May 11, 2017

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova ® lid and lash hygiene product for the domestic eye care market, announces that it...

NovaBay Pharmaceuticals Reports 2016 Full Year And Fourth Quarter Financial Results And Provides 2017 Financial Guidance

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a pharmaceutical company focusing on commercializing its prescription Avenova ® lid and lash hygiene product for the domestic eye care market, reports financial...

NovaBay Pharmaceuticals To Hold 2016 Fourth Quarter And Full Year Conference Call On March 23, 2017

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova ® lid and lash hygiene product for the domestic eye care market, announces that it...

NovaBay Pharmaceuticals To Present Features And Benefits Of The Intelli-Case At FDA Public Advisory Meeting

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a pharmaceutical company focusing on commercializing its Avenova® lid and lash hygiene in the domestic eye care market, today announced that it has been...

NovaBay Pharmaceuticals To Present At 29th Annual ROTH Conference

NovaBay ® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® lid and lash hygiene for the domestic eye care market, announces that Chairman,...

NovaBay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016

NovaBay Pharmaceuticals Announces Preliminary Sales For The Fourth Quarter Of 2016

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® lid and lash hygiene for the domestic eye care market, announces that Avenova...

NovaBay To Present At LD Micro Main Event

NovaBay To Present At LD Micro Main Event

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova® lid and lash hygiene product for the domestic eye care market, announces that Chairman,...

NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results

NovaBay Pharmaceuticals Reports 2016 Third Quarter Financial Results

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova ® lid and lash hygiene product for the domestic eye care market, reports financial...

TheStreet Quant Rating: E+ (Sell)